HLTH.L vs. WBIO.L
HLTH.L (SPDR® MSCI Europe Health Care UCITS ETF) and WBIO.L (WisdomTree BioRevolution UCITS ETF USD Acc) are both Health & Biotech Equities funds - HLTH.L tracks the MSCI World/Health Care NR USD while WBIO.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 3 years, HLTH.L returned 2.79%/yr vs 0.95%/yr for WBIO.L. At a 0.48 correlation, their price movements are largely independent. HLTH.L charges 0.18%/yr vs 0.45%/yr for WBIO.L.
Performance
HLTH.L vs. WBIO.L - Performance Comparison
Loading charts...
Different Trading Currencies
HLTH.L is traded in EUR, while WBIO.L is traded in GBp. To make them comparable, the WBIO.L values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, HLTH.L achieves a -1.46% return, which is significantly lower than WBIO.L's 11.40% return.
HLTH.L
- 1D
- 3.12%
- 1M
- 1.53%
- YTD
- -1.46%
- 6M
- -0.41%
- 1Y
- 6.14%
- 3Y*
- 2.79%
- 5Y*
- 5.77%
- 10Y*
- 6.14%
WBIO.L
- 1D
- 4.26%
- 1M
- 4.29%
- YTD
- 11.40%
- 6M
- 11.52%
- 1Y
- 46.93%
- 3Y*
- 0.95%
- 5Y*
- —
- 10Y*
- —
HLTH.L vs. WBIO.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
HLTH.L SPDR® MSCI Europe Health Care UCITS ETF | -1.46% | 7.01% | 4.14% | 7.61% | -3.78% | 3.20% |
WBIO.L WisdomTree BioRevolution UCITS ETF USD Acc | 11.40% | 7.66% | -9.93% | -3.86% | -23.04% | 0.40% |
Correlation
The correlation between HLTH.L and WBIO.L is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.54 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.45 |
Correlation (All Time) Calculated using the full available price history since Dec 10, 2021 | 0.48 |
The correlation between HLTH.L and WBIO.L has been stable across timeframes, ranging from 0.45 to 0.54 - a consistent structural relationship.
HLTH.L vs. WBIO.L - Sectors Allocation Comparison
Sectors
HLTH.L
WBIO.L
Healthcare
Basic Materials
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
HLTH.L
WBIO.L
Basic Materials
HLTH.L
-
WBIO.L
Communication Services
HLTH.L
-
WBIO.L
-
Consumer Cyclical
HLTH.L
-
WBIO.L
-
Consumer Defensive
HLTH.L
-
WBIO.L
Energy
HLTH.L
-
WBIO.L
-
Financial Services
HLTH.L
-
WBIO.L
-
Industrials
HLTH.L
-
WBIO.L
-
Real Estate
HLTH.L
-
WBIO.L
-
Technology
HLTH.L
-
WBIO.L
-
Utilities
HLTH.L
-
WBIO.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HLTH.L vs. WBIO.L — Risk / Return Rank
HLTH.L
WBIO.L
HLTH.L vs. WBIO.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR® MSCI Europe Health Care UCITS ETF (HLTH.L) and WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HLTH.L | WBIO.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.39 | ||
| Sortino ratioReturn per unit of downside risk | -1.82 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.29 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 0.49 | 3.72 | -3.24 |
| Martin ratioReturn relative to average drawdown | 1.07 | 9.37 | -8.29 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HLTH.L | WBIO.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.37 | 1.76 | -1.39 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.37 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.39 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | -0.20 | +0.55 |
Drawdowns
HLTH.L vs. WBIO.L - Drawdown Comparison
The maximum HLTH.L drawdown since its inception was -26.57%, smaller than the maximum WBIO.L drawdown of -51.68%. Use the drawdown chart below to compare losses from any high point for HLTH.L and WBIO.L.
Loading charts...
Drawdown Indicators
| HLTH.L | WBIO.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.57% | -51.68% | +25.11% |
Max Drawdown (1Y)Largest decline over 1 year | -12.57% | -12.55% | -0.02% |
Max Drawdown (3Y)Largest decline over 3 years | -26.57% | -39.27% | +12.70% |
Max Drawdown (5Y)Largest decline over 5 years | -26.57% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -26.57% | — | — |
Current DrawdownCurrent decline from peak | -10.88% | -20.67% | +9.79% |
Average DrawdownAverage peak-to-trough decline | -9.38% | -27.43% | +18.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.71% | 5.00% | +0.71% |
Volatility
HLTH.L vs. WBIO.L - Volatility Comparison
The current volatility for SPDR® MSCI Europe Health Care UCITS ETF (HLTH.L) is 5.58%, while WisdomTree BioRevolution UCITS ETF USD Acc (WBIO.L) has a volatility of 6.69%. This indicates that HLTH.L experiences smaller price fluctuations and is considered to be less risky than WBIO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HLTH.L | WBIO.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.58% | 6.69% | -1.11% |
Volatility (6M)Calculated over the trailing 6-month period | 11.64% | 17.02% | -5.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.68% | 26.69% | -10.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.59% | 24.10% | -8.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.69% | 24.10% | -8.41% |
HLTH.L vs. WBIO.L - Expense Ratio Comparison
HLTH.L has a 0.18% expense ratio, which is lower than WBIO.L's 0.45% expense ratio.
Dividends
HLTH.L vs. WBIO.L - Dividend Comparison
Neither HLTH.L nor WBIO.L has paid dividends to shareholders.
Frequently Asked Questions
HLTH.L and WBIO.L have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, HLTH.L is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
HLTH.L is cheaper with a 0.18% expense ratio, compared with 0.45% for WBIO.L.
HLTH.L tracks MSCI World/Health Care NR USD, while WBIO.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: State Street and WisdomTree. Their fees differ too: 0.18% for HLTH.L and 0.45% for WBIO.L.
Find the right allocation for HLTH.L and WBIO.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer